...
首页> 外文期刊>Organic letters >Stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc), a new potent hexosaminidase inhibitor
【24h】

Stereoselective synthesis of 2-acetamido-1,2-dideoxyallonojirimycin (DAJNAc), a new potent hexosaminidase inhibitor

机译:立体选择性合成2-乙酰氨基-1,2-二脱氧alalojirimycin(DAJNAc),一种新的强己糖胺酶抑制剂

获取原文
获取原文并翻译 | 示例

摘要

A practical synthesis of the previously unreported N-acetyl-d-allosamine glycomimetic DAJNAc is described. The reaction sequence involves Pd-catalyzed allylic substitution by phthalimide in an azaheterobicyclic scaffold as the key step. The new iminosugar resulted in being a stronger β-N- acetylglucosaminidase (human placenta) competitive inhibitor than the d-gluco (DNJNAc) and d-galacto (DGJNAc) stereoisomers.
机译:描述了以前未报道的N-乙酰基-d-allosamine糖模拟物DAJNAc的实用合成。反应顺序涉及在氮杂杂双环支架中邻苯二甲酰亚胺催化Pd催化的烯丙基取代,这是关键步骤。新的亚氨基糖比β-葡萄糖(DNJNAc)和d-半乳糖(DGJNAc)立体异构体具有更强的β-N-乙酰氨基葡糖苷酶(人胎盘)竞争性抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号